Names and pronunciation
(mil′-te-foe′-seen) Impavido
PDF page 894
Drug reference
(mil′-te-foe′-seen) Impavido
PDF page 894
Func. class.: Antiprotozoal/ antileishmanial
PDF page 894
USES: Treatment of visceral leishman- iasis caused by L. donovani, mucosal leishmaniasis caused by L. braziliensis, and cutaneous leishmaniasis caused by L. braziliensis, L. guyanensis, and L. panamensis
PDF page 894
CONTRAINDICATIONS: Hyper- sensitivity, pregnancy
PDF page 894
DOSAGE AND ROUTES • Adult/adolescent/child ≥12 yr and ≥45 kg: PO 50 mg tid × 28 days • Adult/adolescent/child ≥12 yr and 30- 44 kg: PO 50 mg bid × 28 days; HIV guidelines suggest 100 mg daily × 4 wk in adults and adolescents regardless of weight
PDF page 894
Available forms: capsule 50 mg
PDF page 894
• Adult/adolescent/child ≥12 yr and ≥45 kg: PO 50 mg tid × 28 days
PDF page 894
• Adult/adolescent/child ≥12 yr and 30- 44 kg: PO 50 mg bid × 28 days; HIV guidelines suggest 100 mg daily × 4 wk in adults and adolescents regardless of weight
PDF page 894